Predicting Recurrence and Progession of Non Muscle Invasive Urothelial Cell Carcinoma of Bladder by Clinical and Pathological Prognostic Factors
Korean Journal of Urological Oncology
; : 1-10, 2015.
Article
em Ko
| WPRIM
| ID: wpr-34610
Biblioteca responsável:
WPRO
ABSTRACT
About 80% of Bladder cancer is non muscle invasive bladder cancer (NMIBC). Despite of appropriate therapy, a lot of NMIBC recur as a superficial tumor or progress to muscle invasive disease. Several studies about prognostic factors of recurrence and progression have reported a single risk factor variously according to each study. These efforts were developed to predict the risk by scoring system and large-scale studies had been conducted. These studies had limitations that their patients did not receive BCG (bacillus Calmette-Guerin) immunotherapy, immediate intravesical chemotherapy, second-look TUR (transurethral resection) in high-risk group. Through studies to date, patients with NMIBC have showed heterogenous prognosis and a more sophisticated scoring system can give personalized treatment and exact prediction.
Palavras-chave
Texto completo:
1
Índice:
WPRIM
Assunto principal:
Prognóstico
/
Recidiva
/
Projetos de Pesquisa
/
Bexiga Urinária
/
Neoplasias da Bexiga Urinária
/
Fatores de Risco
/
Tratamento Farmacológico
/
Imunoterapia
/
Mycobacterium bovis
Tipo de estudo:
Etiology_studies
/
Prognostic_studies
/
Risk_factors_studies
Limite:
Humans
Idioma:
Ko
Revista:
Korean Journal of Urological Oncology
Ano de publicação:
2015
Tipo de documento:
Article